Showing results (701-710 of 729) with videos related to

Sort By:
Pageof 73
Histopathology|July 9, 2020
Gene fusion characterisation of rare aggressive prostate cancer variants-adenosquamous carcinoma, pleomorphic giant-cell carcinoma, and sarcomatoid carcinoma: an analysis of 19 casesMohamed Alhamar, I Tudor Vladislav, Steven C Smith, et al.
Biorxiv : the Preprint Server for Biology|May 18, 2026
Improving positively tuned voltage indicators for faster kinetics and higher contrastSungmoo Lee, Guofeng Zhang, Yukun Alex Hao, et al.
Biomedicines|October 26, 2024
Altered PLCβ/IP3/Ca2+ Signaling Pathway Activated by GPRCs in Olfactory Neuronal Precursor Cells Derived from Patients Diagnosed with SchizophreniaZuly A Sánchez-Florentino, Bianca S Romero-Martínez, Edgar Flores-Soto, et al.
ESMO Open|May 9, 2022
Access to early-phase clinical trials in older patients with cancer in France: the EGALICAN-2 studyC Baldini, E Charton, E Schultz, et al.
ESMO Open|April 22, 2021
Biases in study design, implementation, and data analysis that distort the appraisal of clinical benefit and ESMO-Magnitude of Clinical Benefit Scale (ESMO-MCBS) scoringB Gyawali, E G E de Vries, U Dafni, et al.
JCI Insight|August 17, 2021
Autophagy-mitophagy induction attenuates cardiovascular inflammation in a murine model of Kawasaki disease vasculitisStefanie Marek-Iannucci, Asli B Ozdemir, Debbie Moreira, et al.
International Journal of Molecular Sciences|August 14, 2025
Interactions Between Prolactin, Intracellular Signaling, and Possible Implications in the Contractility and Pathophysiology of AsthmaEduardo Calixto, Juan C Gomez-Verjan, Marco Cerbón, et al.
Otology & Neurotology : Official Publication of the American Otological Society, American Neurotology Society [And] European Academy of Otology and Neurotology|May 10, 2024
Design and Methods of the Early Age-Related Hearing Loss Investigation Randomized Controlled TrialMichael W Denham, Michelle L Arnold, Victoria A Sanchez, et al.
Gynecologic Oncology|June 6, 2012
A phase 2 trial of flavopiridol (Alvocidib) and cisplatin in platin-resistant ovarian and primary peritoneal carcinoma: MC0261Keith C Bible, Prema P Peethambaram, Ann L Oberg, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 23, 2025
ESMO-Magnitude of Clinical Benefit Scale version 2.0 (ESMO-MCBS v2.0)N I Cherny, S F Oosting, U Dafni, et al.
Pageof 73